(University of Maryland School of Medicine) Effective treatment of clinical depression remains a major mental health issue, with roughly 30 percent of patients who do not respond to any of the available treatments. Researchers at the University of Maryland School of Medicine (UMSOM) have discovered a crucial receptor called mGlu2 that is critical to the mechanism of fast-acting antidepressants such as ketamine when used to treat depression.
from EurekAlert! - Social and Behavioral Science https://ift.tt/2FIaaBz
No comments:
Post a Comment